Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
Dietary nitrate in the form of beet juice reduces restenosis after percutaneous intervention in a randomized trial.
Read Full NewsThe newly approved generic product is expected to perform like other high-quality glatiramer acetate generics, with differences confined mainly to the manufacturer and device, not mechanism or dosing.
Catch up on any of the neurology news headlines you may have missed in December 2025, compiled into 1 place by the NeurologyLive® team.
A recent trial reveals semaglutide's potential for neurological improvement in stroke patients, despite no overall functional recovery benefits.
Nipocalimab Reduces SLE Disease Activity, Meeting JASMINE Study End Point
Pulmonology in 2025: Year in Review
Q4 2025 Recap: Pulmonology News and Updates
Switching Therapists for Psychotherapy Offers No Advantage in MDD
1.
Month-Long Wait Times Caused by US Physician Shortage.
2.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
3.
'Ticking Time Bomb'; Jimmy Carter's Lasting Impact on Cancer; Breast Cancer-CVD Link
4.
FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor
5.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
1.
Managing Hematoma: A Guide to Prevention and Treatment
2.
Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study
3.
Liquid Biopsy: A Game-Changer in T-Cell Lymphoma Detection and Management
4.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
5.
Leukemia: Understanding the Disease and Its Impact on Patients
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
2.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
3.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
5.
Oropharyngeal Cancer in Relation to HPV Status
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge